Author(s): Madhulita Panda*, M. E. Bhanoji Rao, Jnyanaranjan Panda, Ch. Niranjan Patra, Ganesh Patro


DOI: 10.52711/0974-360X.2023.00160   

Address: Madhulita Panda1*, M. E. Bhanoji Rao1, Jnyanaranjan Panda1, Ch. Niranjan Patra1, Ganesh Patro2
1Roland Institute of Pharmceutical Sciences, Berhampur 760010, Ganjam, Odisha.
2College of Pharmaceutical Sciences, Mohuda, Ganjam, Odisha, India.
*Corresponding Author

Published In:   Volume - 16,      Issue - 2,     Year - 2023

The utility of lipid-based oral formulations has been familiar for many years. There are an enormous variety of polymeric materials used to modify the delivery platform along with enhancement of therapeutic efficacy. Gelucires are a family of lipid-based excipients comprising of glycerides and esters of polyethylene glycol, these two components conferring hydrophobic and hydrophilic properties to the vehicle. Gelucire is used to enhance the drug’s physicochemical properties, as well as controlled release matrices. This review intends to give a critical overview of the published literature on the properties, chemical nature, advantages over other polymers, methods of characterization of gelucire containing formulations, applications and patents containing various grades of gelucires.

Cite this article:
Madhulita Panda*, M. E. Bhanoji Rao, Jnyanaranjan Panda, Ch. Niranjan Patra, Ganesh Patro. Gelucire: A Flexible Formulation Excipients. Research Journal of Pharmacy and Technology 2023; 16(2):955-1. doi: 10.52711/0974-360X.2023.00160

Madhulita Panda*, M. E. Bhanoji Rao, Jnyanaranjan Panda, Ch. Niranjan Patra, Ganesh Patro. Gelucire: A Flexible Formulation Excipients. Research Journal of Pharmacy and Technology 2023; 16(2):955-1. doi: 10.52711/0974-360X.2023.00160   Available on:

1.    Ankita DS, Yogesh SC. Recent scenario of gelucires in solid dispersion techniques. World Journal of Pharmaceutical Research. 2015; 4(7): 832-850.
2.    Ashwini G, Ashwin K. Gelucire: an emerging polymer in pharmaceuticals. International Journal of Recent Scientific Research. 2020; 11(6): 39054-39060. DOI:
3.    Priyanka DD, Poonam YP. Gelucire: a novel tool in formulation of poorly soluble drugs. World Journal of Pharmaceutical Research. 2018; 7(11): 471-481.
4.    Chambina O, Janninb V, Champion D, Chevaliera C, Rochat-Gonthiera, Pourcelota Y. Influence of cryogenic grinding on properties of a self-emulsifying formulation. International Journal of Pharmaceutics. 2004; 278: 79-89. DOI: 10.1016/j.ijpharm.2004.02.033.
5.    Panigrahi KC, Patra CN, Jena GK, Ghose D, Jena J, Panda SK, Sahu M. Gelucire: A versatile polymer for modified release drug delivery system. Future Journal of Pharmaceutical Sciences. 2018; 4: 102-108.
6.    Patil PR, Biradar SV, Paradkar AR. Extended release felodipine self-nano emulsifying system. AAPS Pharm Sci Tech. 2009; 10: 515-523. doi: 10.1208/s12249-009-9235-0.
7.    Vishnu P, NaveenBabu K, Sunitha RM. Formulation and evaluation of candesartan cilexetil floating tablets by melt granulation technique. International Journal of Research in Pharmacy and Chemistry. 2015; 5(2): 373-379.
8.    Jammula S, Patra CN, Swain S, Panigrahi KC, Nayak S, Dinda SC, Rao ME. Design and characterization of cefuroxime axetil biphasic floating minitablets. Drug Delivery. 2015; 22(1): 125-135.
9.    Shimpi S, Chauhan B, Mahadik KR, Paradkar A. Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation. AAPS Pharm Sci Tech. 2004; 5(3): 51-56. DOI: 10.1208/pt050343
10.    Adel S, ElKasabgy NA. Design of innovated lipid-based floating beads loaded with an antispasmodic drug: in-vitro and in-vivo evaluation. Journal of Liposome Research. 2014; 24(2): 136-149. doi: 10.3109/08982104.2013.857355
11.    Patel DM, Patel MJ, Patel AN, Patel CN. Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine. International Journal of Pharmaceutical Investigation. 2011; 1(4): 247-254. doi: 10.4103/2230-973X.93006
12.    Thakkar VT, Shah PA, Soni TG, Parmar MY, Gohel MC, Gandhi TR. Fabrication and evaluation of levofloxacin hemihydrate floating tablet. Research in Pharmaceutical Sciences. 2008; 3(2): 1-8.
13.    Siripuram PK, Bandari S, Jukanti R, Veerareddy PR. Formulation and characterization of floating gelucire matrices of metoprolol. Dissolution Technologies. 2010; 8: 34-39.
14.    Kishore BA, Ramana MV. In vitro and in vivo evaluation of quetiapine fumarate controlled gastroretentive floating drug delivery system. International Journal of Drug Delivery. 2016; 8:12-22.
15.    de los Santos CJJ, Perez-Martinez JI, Gomez-Pantoja ME, Moyano JR. Enhancement of albendazole dissolution properties using solid dispersions with gelucire 50/13 and PEG 15000. Journal of Drug Delivery Science and Technology. 2017; 30: 1-12.
16.    Chowdary KPR, Ramya K, Aishwarya KVNR, Adilakshmi KA. Factorial study on the enhancement of dissolution rate of aceclofenac by solid dispersion in starch phosphate and gelucire. International Journal of Research in Pharmacy and Chemistry. 2012; 2(4): 907-912.
17.    Tapan KP, Debajyoti D, Lalatendu P. Formulation development of solid dispersions of bosentan using gelucire 50/13 and poloxamer 188. Journal of Applied Pharmaceutical Science. 2016; 6(09): 027-033. DOI: 10.7324/JAPS.2016.60904
18.    Thorat VP, Mahaparale PR, Gonjari ID. Fast dissolving drug delivery system of cilnidipine using Gelucire 50/13. Research Journal of Pharmacy and Technology. 2019; 12(5): 2185-2188. DOI: 10.5958/0974-360X.2019.00364.0
19.    Jammula S, Patra CN, Swain S, Panigrahi KC, Patro AP, Beg S, Dinda SC, Rao ME. Improvement in the dissolution rate and tableting properties of cefuroxime axetil by melt-granulated dispersion and surface adsorption. Acta Pharmaceutica Sinica B. 2013; 3(2): 113-122. DOI: 10.1016/j.apsb.2013.01.001
20.    Hazzah HA, Farid RM, Nasra M, Hazzah WA, El‐Massik MA, Abdallah OY. Gelucire‐based nanoparticles for curcumin targeting to oral mucosa: preparation, characterization and antimicrobial activity assessment. Journal of Pharmaceutical Sciences. 2015; 104: 3913-3924. DOI: 10.1002/jps.24590
21.    Upadhyay P, Baral A, De T. Formulation and development of floating multiparticulate drug delivery system of antidiabetic drug by hot melt technique. International Journal of Advances in Pharmaceutical Sciences. 2013; 4(4): 587-601. DOI: 10.4314/tjpr.v11i3.4 DOI: 10.4314/tjpr.v11i3.4
22.    Albertini B, Sabatino MD, Melegari C, Passerini N. Formulation of spray congealed microparticles with selfemulsifying ability for enhanced glibenclamide dissolution performance. Journal of Microencapsulation. 2015; 32: 181-192. doi: 10.3109/02652048.2014.985341
23.    Devireddy SR, Veerareddy PR. Solubility and bioavailability improvement of glicclazide by solid dispersions. International Journal of Drug Delivery. 2012; 4(4): 455-461.
24.    Jang SW, Choi YW, Kang MJ. Preparation of solid dispersion of everolimus in gelucire 50/13 using melt granulation technique for enhanced drug release. Bulletin of the Korean Chemical Society. 2014; 35(7): 1939-1943.
25.    Shinde SS, Hosmani AH. Preparation and evaluation lipid nanoparticles of fenofibrate obtained by spray drying technique. Pharmacophore. 2014; 5(1): 85-93.
26.    Pestieau A, Krier F, LebrunP, Brouwers A, Streel B, Evrard B. Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation. International Journal of Pharmaceutics. 2015; 485: 295-305. DOI: 10.1016/j.ijpharm.2015.03.027
27.    Mohamed AA, Shalam MH. Enhancement of dissolution and in vivo evaluation of lornoxicam ternary system with Gelucire 50/13 and polysorbate 80. Research Journal of Pharmacy and Technology. 2016; 9(2): 121-127. DOI: 10.5958/0974-360X.2016.00019.6
28.    Khobragade DS, Wankar J, Patil AT, Potbhare MS, Lakhotiya CL, Umathe SN. A novel practical approach for enhancement of bioavailability of a poorly water-soluble drug by hot melt coating technique. International Journal of Pharmaceutical Sciences Review and Research. 2014; 26(1): 258-263.
29.    Garg NK, Singh B, Tyagi RK, Sharma G, Katare OP. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model. Colloids and Surfaces B: Biointerfaces. 2016; 147: 17-24. DOI: 10.1016/j.colsurfb.2016.07.046
30.    Upadhyay P, Pandit JK, Wahi AK. Studies on biological macromolecules lipid-gelucire based gastroretentive multiparticulate. International Journal of Biological Macromolecules. 2014; 67: 463-477. DOI: 10.1016/j.ijbiomac.2014.03.045
31.    Ammar HO, Ghorab MM, Mahmoud AA, Noshi SH. Formulation of risperidone in floating microparticles to alleviate its extra pyramidal side effects. Future Journal of Pharmaceutical Sciences. 2016; 2: 43-59.
32.    Kim MS, Kim JS, Cho W, Cha KH, Park HJ, Park J, Hwang SJ. Super saturatable formulations for the enhanced oral absorption of sirolimus. International Journal of Pharmaceutics. 2013; 445: 8-116. DOI: 10.1016/j.ijpharm.2013.01.067
33.    Patel P, Mehta T, Panchal S.  Preparation, evaluation and comparison of lipid-based drug delivery systems of tacrolimus. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(2): 588-591.
34.    Sahoo A, Bhilegaonkar S. Suitability of different grades of gelucire and peg-6000 for solubility enhancement of tinidazole by process of solid dispersion. International Journal of Pharmaceutical Sciences and Research. 2015; 6(4): 1460-1464. DOI: 10.13040/IJPSR.0975-8232.6(4).1460-64
35.    Chella N, Tadikonda R. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs-a case study with valsartan. Drug Development and Industrial Pharmacy. 2015; 41: 888-897. DOI: 10.3109/03639045.2014.911308
36.    Juarezsoberanez D, Villafuerterobles L. Gelucire 39/01 as excipient for gastroretentive metronidazole sustained delivery. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(2): 86-91.
37.    Saxena A, Mishra AK, Verma N, Bhattacharya SS, Ghosh A, Verma A, Pandit JK. Gelucire based in situ gelling emulsions: a potential carrier for sustained stomach specific delivery of gastric irritant drugs. BioMed Research International. 2013; 1-11.
38.    Paulina CT, Leopoldo VR. Gelucire 39/01 as a matrix for controlled release of ranitidine hydrochloride from floating granules. Revista Mexicana De Ciencias Farmaceuticas. 2014; 45(3): 54-64.
39.    Chauhan B, Shimpi S, Mahadik K, Paradkar A. Preparation and evaluation of floating risedronate sodium gelucire 39/01 matrices. Acta Pharmaceutica. 2004; 54(3): 205-214.
40.    Madgulkar AR, Bhalekar MR, Padalkar RR. Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength. AAPS Pharm Sci Tech. 2009; 10(2): 574-581. doi: 10.1208/s12249-009-9237-y
41.    Kalpana M, Sistla R, Shastri NR. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug-an in vitro and an in vivo study. Drug Delivery. 2015; 22: 418-426. DOI: 10.3109/10717544.2013.878965
42.    Anupama S, Surinder G, Birendra S, Goyal N. Design, optimization, preparation and evaluation of solid dispersions of albendazole using factorial design. Der Pharmacia Sinica. 2011; 2(5): 30-42.
43.    Lacramioara O, Cristian G, Marcel P, Iulian S, Corneliu M, Daniel T, Lenuta P, Anca GG. Alendronate loaded modified drug delivery lipid particles intended for improved oral and topical administration. Molecules. 2016; 21: 858-874. DOI: 10.3390/molecules21070858
44.    Breitkreitz MC, Sabin GP, Polla G, Poppi RJ. Characterization of semi-solid self-emulsifying drug delivery systems (SEDDS) of atorvastatin calcium by raman image spectroscopy and chemometrics. Journal of Pharmaceutical and Biomedical Analysis. 2013; 73: 3-12. DOI: 10.1016/j.jpba.2012.03.054
45.    Antunes A, Geest B, Vervaet C, Remon JP. Gelucire 44/14 based immediate release formulations for poorly water-soluble drugs. Drug Development and Industrial Pharmacy. 2013; 39(5): 791-798. DOI: 10.3109/03639045.2012.709251
46.    Borhade V, Pathakb S, Sharmab S, Patravalea V. Pharmaceutical nanotechnology Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation. International Journal of Pharmaceutics. 2012; 431: 138-148. DOI: 10.1016/j.ijpharm.2011.12.040
47.    Jitendra DM, Monika K, Chhaya HG. Sodium alginate curcumin floating beads containing curcumin solid dispersion: preparation and evaluation of stability, solubility and bioavailability. World Journal of Pharmacy and Pharmaceutical Sciences. 2016; 5(7): 1993-2008. DOI : 10.20959/wjpps20167-7203
48.    Wehrung D, Geldenhuys WJ, Bil, Oyewumi MO. Biocompatibility, efficacy and biodistribution of gelucire stabilized nanoparticles engineered for docetaxel delivery. Journal of Nanoscience and Nanotechnology. 2012; 12: 2901-2911. DOI: 10.1166/jnn.2012.5789
49.    Eedara BB, Bandari S. Lipid-based dispersions of exemestane for improved dissolution rate and intestinal permeability: in vitro and ex vivo characterization. Artificial Cells, Nanomedicine and Biotechnology. 2016; 45: 917-927. DOI: 10.1080/21691401.2016.1193023
50.    Kanaujia P, Ng WK, Tan RB. Solid self-emulsifying drug delivery system (S-SEDDS) for improved dissolution rate of fenofibrate. Journal of Microencapsulation. 2014; 31: 293-298. DOI: 10.3109/02652048.2013.843601
51.    Wehrung D, BiL, Geldenhuys WJ, Oyewumi MO. Antitumor efficacy and tolerability of systemically administered gallium acetylacetonate-loaded gelucire-stabilized nanoparticles. Journal of Biomedical Nanotechnology. 2013; 9: 1029-1040. DOI: 10.1166/jbn.2013.1598
52.    Sambasivarao A. Formulation and evaluation of immediate release tablets of glimepiride by using solid dispersion technique using gelucires. World Journal of Pharmacy and Pharmaceutical Sciences. 2016; 5(5): 1659-1678.
53.    Patil AM, Nitalikar MM, Mohite SK. Improvement of dissolution profile of lornoxicam by solid dispersion using spray drying technique. International Journal of Universal Pharmacy and Bio Sciences. 2014; 3(5):  66-72.
54.    Amaresh CS, Sunil KK, Subas CD, Sujit D, Suchismita P. Formulation development of immediate release solid dispersion tablets of lovastatin with enhanced dissolution. Research Journal of Pharmacy and Technology. 2019; 12(10): 4963-4972.
55.    Faisal W, Ruane-O’Hora T, O’Driscoll CM, Griffin BT. A novel lipid-based solid dispersion for enhancing oral bioavailability of lycopene-in vivo evaluation using a pig model. International Journal of Pharmaceutics. 2013; 453: 307-314. DOI: 10.1016/j.ijpharm.2013.06.027
56.    Fawziya WA, Gehan FB, Nahla SB, Alaa FA, Athba KA, Bashair MS Haifa AA, Sarah AA. Formulation and evaluation of fast dissolving film of meloxicam. International Journal of Research in Pharmacology & Pharmacotherapeutics. 2017; 6(1): 16-27.
57.    Arza RAK, Kumar BV. Development and evaluation of gastroretentive floating matrix tablets of moxifloxacin HCL. The Pharma Letter. 2016; 8: 140-149.
58.    Cerpnjak K, Zvonar A, Vrecer F, Gasperlin M. Characterization of naproxen-loaded solid SMEDDSs prepared by spray drying: The effect of the polysaccharide carrier and naproxen concentration. International Journal of Pharmaceutics, 2015; 485: 215-228. DOI: 10.1016/j.ijpharm.2015.03.015
59.    Cavallari C, Fini A, Ceschel G. Design of olanzapine/lutrol solid dispersions of improved stability and performances. Pharmaceutics. 2013; 5(4): 570-590. DOI: 10.3390/pharmaceutics5040570
60.    Karatas A, Bekmezci S. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules. Acta Poloniae Pharmaceutica - Drug Research. 2013; 70(5): 883-897.
61.    Falconer JR, Wen J, Zargar-Shoshtari S, Chen JJ, Farid M, El Maghraby GM, Alany RG. Evaluation of progesterone permeability from supercritical fluid processed dispersion systems. Pharmaceutical Development and Technology. 2014; 19: 238-246. DOI: 10.3109/10837450.2013.769570
62.    Babu AK, Ramana MV. Development and in vivo evaluation of gastroretentive floating tablets of antipsychotic drug risperidone. International Journal of Pharmacy and Pharmaceutical Sciences. 2016; 8: 43-52. DOI:
63.    Jatwani S, Rana AC, Singh G, Aggarwal G. Solubility and dissolution enhancement of simvastatin using synergistic effect of hydrophilic carriers. Der Pharmacia Lettre. 2011; 3(6): 280-293.
64.    Ochiuz L, Grigoras C, Popa M, Stoleriu I, Munteanu C, Timofte D, Profire L, Grigoras AG. Alendronate-loaded modified drug delivery lipid particles intended for improved oral and topical administration. Molecules. 2016; 21: 858-873. DOI: 10.3390/molecules21070858
65.    Sistla R, Shastri NR. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drugs an in vitro and an in vivo study. Drug Delivery. 2014; 22 (3): 418-426. DOI: 10.3109/10717544.2013.878965
66.    El Massik MA. Development of cetirizine chewable tablets with inhibited bitterness using liquisolid compact technology. Alexandria Journal of Pharmaceutical Sciences. 2006; 20: 11-16.
67.    Massik MA, Abdallah OY, Galal S, Daabis NA. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation. Drug Development and Industrial Pharmacy. 2003; 29(5): 531-543. DOI: 10.1081/ddc-120018642
68.    Barakat NS, Al-Suwayeh SA, Taha EI, Bakry AE. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma. Journal of Drug Targeting. 2011; 19(5): 365-372. DOI: 10.3109/1061186X.2010.504264
69.    Jannin V, Di Cuia M, Chevrier S, Faure A, Chavant Y, Voutsinas C, Demarne F. Characterization of a new self-emulsifying excipient to expand formulation options for poorly soluble drugs: Gelucire® 48/16. Research gate. 2012.
70.    Ganesh M, Chandra SB, Madhusudan Y. Design and optimization of rivaroxaban lipid solid dispersion for dissolution enhancement using statistical experimental design. Asian Journal of Pharmaceutics. 2016; 10(1): 59-64.
71.    Swetha RB, Tripura SP. Formulation and evaluation of solid lipid nanoparticles of etoricoxib by employing glyceryl monostearate and gelucire 48/16. Indo American Journal of Pharmaceutical Research. 2019; 9(2): 1890-1899.
72.    Serena B, Beatrice A, Nadia P. Different BCS class II drug-gelucire solid dispersions prepared by spray congealing: evaluation of solid state properties and in vitro performances. Pharmaceutics. 2020; 12: 1-19. doi: 10.3390/pharmaceutics12060548
73.    Pahwa R, Kumar S, Saini N, Kumar V. Gelucire mediated gastric floating drug delivery systems. Pharm Lett. 2012; 4: 1038-1043.
74.    Farah N, Bambarkar S, Jannin V, Kapadia C, Nagarsenker M, Marwah M. Pharmaceutical composition comprising solid dispersion of BCS class II drugs with Gelucires. WIPO patent application WO/2016/005994. Jan. 2016.
75.    Gursoy RN, Cevik O. Lipid-based nanocarrier systems for using cancer treatment. European patent EP2790683. Jun. 2016.
76.    Podolski J. Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride. United States patent application 20090149434. Jun. 2009
77.    Tehim A. Pharmaceutical formulations for 1,4-dihyrdropyridine compounds having improved solubility. WIPO patent application WO/2008/058234. May. 2008.
78.    Francis V, Cecile S, Philippe B. Pharmaceutical semi-solid composition of sotretinoin. United States Patent No. US 7.435,427 B2. Oct. 2008.
79.    Martini A. Semi-solid formulations for immediate release intended for the oral administration of drugs. United States Patent Application 20070141140. Jun. 2007.
80.    Johannsson F. Formulations of finasteride. United States patent application. 20060099251. May. 2006.
81.    Borovac T, Neves C, Peracchia MT. Semi-solid formulations for the oral administration of taxoids. WIPO patent application WO/2005/013968. Feb. 2005.
82.    Jamali F. Composition for enhanced absorption of NSAIDS. WIPO patent application WO/2002/083105. Oct. 2002.
83.    Craig D, Barker S, Yuen K. Drug delivery system, WIPO patent application WO/2002/045696. Jun. 2002.
84.    Barnwell SG, Burns SJ, Higginbottom S, Whelan IP. Biphasic capsule formulation. European patent EP0734253. Feb. 2002.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available